ATE225368T1 - Verfahren zur reinigung von faktor viii - Google Patents

Verfahren zur reinigung von faktor viii

Info

Publication number
ATE225368T1
ATE225368T1 AT95937285T AT95937285T ATE225368T1 AT E225368 T1 ATE225368 T1 AT E225368T1 AT 95937285 T AT95937285 T AT 95937285T AT 95937285 T AT95937285 T AT 95937285T AT E225368 T1 ATE225368 T1 AT E225368T1
Authority
AT
Austria
Prior art keywords
factor viii
aqueous solution
pct
gel
present
Prior art date
Application number
AT95937285T
Other languages
English (en)
Inventor
Anna-Lisa Smeds
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Application granted granted Critical
Publication of ATE225368T1 publication Critical patent/ATE225368T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT95937285T 1994-11-14 1995-11-14 Verfahren zur reinigung von faktor viii ATE225368T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403914A SE503424C2 (sv) 1994-11-14 1994-11-14 Process för rening av rekombinant koagulationsfaktor VIII
PCT/SE1995/001350 WO1996015140A1 (en) 1994-11-14 1995-11-14 Process for purification of factor viii

Publications (1)

Publication Number Publication Date
ATE225368T1 true ATE225368T1 (de) 2002-10-15

Family

ID=20395963

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95937285T ATE225368T1 (de) 1994-11-14 1995-11-14 Verfahren zur reinigung von faktor viii

Country Status (13)

Country Link
US (1) US6005082A (de)
EP (1) EP0792281B1 (de)
JP (1) JP3871710B2 (de)
AT (1) ATE225368T1 (de)
AU (1) AU691993B2 (de)
CA (1) CA2202873C (de)
DE (1) DE69528471T2 (de)
DK (1) DK0792281T3 (de)
ES (1) ES2182915T3 (de)
NZ (1) NZ295810A (de)
PT (1) PT792281E (de)
SE (1) SE503424C2 (de)
WO (1) WO1996015140A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2634663C (en) 1999-02-22 2009-08-25 University Of Connecticut Novel albumin-free factor viii formulations
US6822081B2 (en) * 2000-01-13 2004-11-23 Max-Planck Gesellschaft zur Förderung der Wissenschaften e.V. Process for the isolation and/or purification of a proteinaceous material
ES2343023T3 (es) 2000-03-27 2010-07-21 Genetics Institute, Llc Procedimientos para purificar proteinas altamente anionicas.
ES2266535T3 (es) * 2001-06-05 2007-03-01 Genetics Institute, Llc Procedimientos relativos a la purificacion de proteinas altamente anionicas.
DE602004026343D1 (de) * 2003-10-24 2010-05-12 Amgen Inc Verfahren zur aufreinigung von proteinen in einer durchflussfraktion aus der chromatographie mit hydrophoben wechselwirkungen
WO2009007451A1 (en) * 2007-07-11 2009-01-15 Novo Nordisk A/S Purification of factor viii using a mixed-mode or multimodal resin
EP2385825B1 (de) 2008-11-07 2018-10-10 University of Connecticut Faktor-viii-formulierungen
CN102741275B (zh) 2009-08-24 2016-08-03 阿穆尼克斯运营公司 凝血因子ix组合物及其制备和使用方法
EP2572190B1 (de) 2010-05-19 2015-01-28 F.Hoffmann-La Roche Ag Hydrophobes interaktionschromatografieverfahren
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
LT3564260T (lt) 2012-02-15 2023-01-10 Bioverativ Therapeutics Inc. Viii faktoriaus kompozicijos ir jų gamybos bei panaudojimo būdai
EP2822577B1 (de) 2012-02-15 2019-02-06 Bioverativ Therapeutics Inc. Rekombinante faktor-viii-proteine
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
TWI667255B (zh) 2013-08-14 2019-08-01 美商生物化學醫療公司 因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途
EP3052640A2 (de) 2013-10-04 2016-08-10 AbbVie Inc. Verwendung von metallionen zur modulation von proteinglykosylierungsprofilen rekombinanter proteine
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
SG11201605242YA (en) 2014-01-10 2016-07-28 Biogen Ma Inc Factor viii chimeric proteins and uses thereof
IL257231B (en) 2015-08-03 2022-09-01 Bioverativ Therapeutics Inc Factor ix fusion proteins and methods of making and using same
MX2019006444A (es) 2016-12-02 2019-10-30 Bioverativ Therapeutics Inc Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos.
JP7253505B2 (ja) 2017-06-23 2023-04-06 武田薬品工業株式会社 第ｖｉｉｉ因子亜種の精製
SI3793588T1 (sl) 2018-05-18 2025-07-31 Bioverativ Therapeutics Inc. Postopki zdravljenja hemofilije A

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
US5595886A (en) * 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
GB9211538D0 (en) * 1992-06-01 1992-07-15 Blake David R Antiinflammatory agent
WO1994007510A1 (en) * 1992-10-02 1994-04-14 Kabi Pharmacia Ab Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
JP3133338B2 (ja) * 1992-12-16 2001-02-05 イムノ・アクチエンゲゼルシャフト ウイルス的に安全な生物学的組成物の調製方法

Also Published As

Publication number Publication date
SE9403914D0 (sv) 1994-11-14
NZ295810A (en) 1998-08-26
DK0792281T3 (da) 2003-02-03
JP3871710B2 (ja) 2007-01-24
WO1996015140A1 (en) 1996-05-23
AU691993B2 (en) 1998-05-28
PT792281E (pt) 2003-02-28
AU3943895A (en) 1996-06-06
DE69528471D1 (de) 2002-11-07
SE503424C2 (sv) 1996-06-10
US6005082A (en) 1999-12-21
CA2202873C (en) 2011-06-21
EP0792281B1 (de) 2002-10-02
JPH10508841A (ja) 1998-09-02
ES2182915T3 (es) 2003-03-16
MX9703470A (es) 1997-07-31
SE9403914L (sv) 1996-05-15
DE69528471T2 (de) 2003-07-10
CA2202873A1 (en) 1996-05-23
EP0792281A1 (de) 1997-09-03

Similar Documents

Publication Publication Date Title
DE69528471D1 (de) Verfahren zur reinigung von faktor viii
DE4435485C1 (de) Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
DE3486423T3 (de) Neue Faktor VIII Polypeptidkoagulantien
DE359593T1 (de) Chromatographische trennung von plasmaproteinen.
ES2174957T3 (es) Proteinas purificadas de envoltura de virus de la hepatitis c para uso diagnostico y terapeutico.
KR860008276A (ko) 단백질이 생성된 배양기로 부터 그것을 추출, 정제하는 방법
EP0077870A2 (de) Verfahren zur Wärmebehandlung einer den menschlichen Blutgerinnungsfaktor VIII enthaltenden wässrigen Lösung
MX9703552A (es) Proceso de purificacion de factor viii.
EP0202853A2 (de) Die Wirksamkeit des Hemmstoffes vom Faktor VIII neutralisierendes Polypeptid und dieses enthaltende therapeutische Zusammensetzung
EP0567448B1 (de) Verfahren zur Herstellung von Faktor VIII
JPH0381290A (ja) 精製されたアルブミン溶液の製造方法
JPH0545600B2 (de)
DE3584775D1 (de) Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken.
EP0117064A2 (de) Verfahren zur Hitzebehandlung vom Blutgerinnungsfaktor VIII
AT396937B (de) Verfahren zur aktivierung von blutgerinnungsfaktoren
DE69738397D1 (de) Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma
ATE190492T1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
ATE263779T1 (de) Wässrige proteinzusammensetzung, enthaltende glykoproteine, verfahren zur herstellung und verwendungen
AT407750B (de) Verfahren zur herstellung einer vwf-präparation
US4769336A (en) Treatment of factor VIII inhibitors
CA1301680C (en) Process of preparing physiologically active proteinaceous solutions
JP2678193B2 (ja) ヒト血漿由来血液凝固第ｘ▲ｉｉｉ▼因子の製造方法
KR910016339A (ko) Pp4-델타, 이의 제조방법 및 용도
DK563886A (da) Terapeutisk komposition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0792281

Country of ref document: EP